Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
71.05 CHF | +0.35% | -2.35% | +38.51% |
26/04 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
25/04 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 1.25B | |
+30.38% | 684B | |
+29.55% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.36% | 240B | |
+9.43% | 208B | |
-7.32% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals N : Research Partners Lowers Price Target on Cosmo Pharmaceuticals, Maintains Buy Recommendation